Real-world (Rw) outcomes in patients (pts) with hormone receptor-positive and human epidermal growth factor receptor-2 negative (HR+/HER2-) metastatic breast cancer (mBC) treated with chemotherapy (CT) in France and Germany

被引：0

作者：

Campone, M. ^{[1
]}

Frenel, J-S. ^{[1
]}

Kiver, V. I. I. ^{[2
,3
,4
]}

Woeckel, A. ^{[5
]}

Kerscher, A. G. ^{[6
]}

Krebs, M. ^{[6
]}

Leal, C. S. ^{[7
]}

Saglimbene, V. M. ^{[8
]}

Trankov, N. ^{[9
]}

Sadetsky, N. ^{[10
]}

Sjekloca, N. ^{[11
]}

Libert, O. ^{[12
]}

Kaushik, A. G. ^{[13
]}

Bocquet, F. ^{[14
]}

机构：

[1] ICO Inst Cancerol Ouest Rene Gauducheau, Dept Med Oncol, St Herblain, France

[2] Charite Univ Med Berlin, Breast Ctr, Dept Gynecol, Berlin, Germany

[3] Free Univ Berlin, Berlin, Germany

[4] Humboldt Univ, Berlin, Germany

[5] Univ Hosp Wurzburg, Dept Obstet & Gynecol, Wurzburg, Germany

[6] Univ Hosp Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany

[7] IQVIA, Epidemiol & Database Studies, Porto Salvo, Portugal

[8] IQVIA Italy, EMEA Real World Methods & Evidence Generat, Milan, Italy

[9] IQVIA, EMEA Real World Methods & Evidence Generat, Sofia, Bulgaria

[10] Gilead Sci Inc, RWE Oncol, Foster City, CA USA

[11] Gilead Sci Europe Ltd, Global Med Affairs, Stockley Pk, England

[12] Gilead Sci SAS, Med Affairs, Boulogne, France

[13] Gilead Sci Inc, Hlth Econ Outcomes Res, Foster City, CA USA

[14] Inst Cancerol Ouest, Data Factory & Analyt, St Herblain, France

来源：

关键词：

D O I：

10.1016/j.annonc.2024.08.322

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

374P

引用

页码：S375 / S376

页数：2